Beatrice Fairbairn
Stock Analyst at Berenberg Bank
(2.18)
# 3,174
Out of 4,835 analysts
9
Total ratings
75%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Beatrice Fairbairn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: HIK Hikma Pharmaceuticals PLC | Maintained: Buy | 2,100p | 1,492p | +40.75% | 5 | Sep 11, 2026 | |
| ETR: OBCK Ottobock SE & Co. KGaA | Reiterated: Hold | €66.00 | €57.80 | +14.19% | 3 | Aug 18, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Hold | CHF 49.00 | CHF 66.26 | -26.05% | 1 | Oct 16, 2025 |
Hikma Pharmaceuticals PLC
Sep 11, 2026
Maintained: Buy
Price Target: 2,100p
Current: 1,492p
Upside: +40.75%
Ottobock SE & Co. KGaA
Aug 18, 2026
Reiterated: Hold
Price Target: €66.00
Current: €57.80
Upside: +14.19%
Sandoz Group AG
Oct 16, 2025
Reiterated: Hold
Price Target: CHF 49.00
Current: CHF 66.26
Upside: -26.05%